These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 17453655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R, Petersen T, Scalia M, Papakostas GI, Farabaugh A, Fava M.
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictors of hopelessness among clinically depressed youth.
    Becker-Weidman EG, Reinecke MA, Jacobs RH, Martinovich Z, Silva SG, March JS.
    Behav Cogn Psychother; 2009 May; 37(3):267-91. PubMed ID: 19368751
    [Abstract] [Full Text] [Related]

  • 6. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep 01; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
    Fava M, McGrath PJ, Sheu WP, Reboxetine Study Group.
    J Clin Psychopharmacol; 2003 Aug 01; 23(4):365-9. PubMed ID: 12920412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pain has a strong negative impact on the fluoxetine response in hospitalized patients with major depressive disorder.
    Lin CH, Lane HY, Chen CC, Juo SH, Yen CF.
    Clin J Pain; 2011 Aug 01; 27(9):805-10. PubMed ID: 21677571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hopelessness across phases of bipolar I or II disorder: a prospective study.
    Valtonen HM, Suominen K, Haukka J, Mantere O, Arvilommi P, Leppämäki S, Isometsä ET.
    J Affect Disord; 2009 May 01; 115(1-2):11-7. PubMed ID: 18678413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.